Enanta Pharmaceuticals
ENTA
#7512
Rank
โ‚น36.81 B
Marketcap
โ‚น1,276
Share price
-1.60%
Change (1 day)
114.74%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2025 : โ‚น7.15 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has โ‚น7.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$โ‚น10.79 B-40.1%
2023-09-30$โ‚น18.02 B-31.07%
2022-09-30$โ‚น26.15 B-11.82%
2021-09-30$โ‚น29.65 B-11.67%
2020-09-30$โ‚น33.57 B2.37%
2019-09-30$โ‚น32.80 B14.92%
2018-09-30$โ‚น28.54 B44.87%
2017-09-30$โ‚น19.70 B9.19%
2016-09-30$โ‚น18.04 B16.6%
2015-09-30$โ‚น15.47 B68.39%
2014-09-30$โ‚น9.18 B32.93%
2013-09-30$โ‚น6.91 B197.78%
2012-09-30$โ‚น2.32 B115.41%
2011-09-30$โ‚น1.07 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AbbVie
ABBV
-โ‚น234.46 Billion-3,378.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น7.151 T 99,897.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.562 T 21,745.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น4.682 T 65,373.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.677 T 23,361.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น4.037 T 56,348.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland